Cancer Research UK logo.
SearchDonate
  • Search

A trial of pelareorep and GM-CSF for glioblastoma (ReoGlio)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Results

Phase:

Phase 1

Details

This trial looked pelareorep (Reolysin), a treatment made from a virus called reovirus. It was for a type of brain tumour called glioblastoma.

The trial was supported by Cancer Research UK. It was open for people to join between 2017 and 2019. The team presented the results at a conference in 2020.

Recruitment start: 19 September 2017

Recruitment end: 31 March 2019

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Susan Short

Supported by

Cancer Research UK

The Brain Tumour Charity

Oncolytics Biotech Inc

Yorkshire Cancer Research

University of Leeds

Other information

This is Cancer Research UK trial number CRUKD/16/007

Last reviewed: 23 Nov 2021

CRUK internal database number: 14314

Help and support